Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymsm', 'obinu', 'lymphoma', 'dlbcl']
#ash22 awesome results of #glofitamab fix-duration therapy of 13 cycles in r/r dlbcl in patients achieving cr #lymsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member